Quality standard
Quality statements
Quality statements
Statement 1 People with haematological cancer have an integrated report produced by a specialist integrated haematological malignancy diagnostic service (SIHMDS) that is shared with the haemato-oncology multidisciplinary team (MDT).
Statement 2 Young people and adults with specific subtypes of non-Hodgkin's lymphoma have staging using fluorodeoxyglucose-positron emission tomography-CT (FDG-PET-CT).
Statement 3 Young people and adults with localised stage IIA follicular lymphoma have local radiotherapy as first-line treatment.
Statement 4 Young people and adults who have completed their treatment for non-Hodgkin's lymphoma or myeloma have a discussion about their end-of-treatment summary plan.